Jubilant Life Sciences Subsidiary Acquires Drug Company In USA
Drug Discovery and Development Solutions Limited, Singapore (DDDSL), a wholly-owned subsidiary of Jubilant Life Sciences Limited, has entered into Stock Purchase Agreement for acquiring 534,194 shares of Common Stock of Inipharm Inc., USA.
1. Industry to which the entity being acquired belongs: Biotechnology
2. Products/line of business: Drug Discovery and Development
3. Cost of acquisition or the price at which the shares are acquired: USD 534.20 (USD Five Hundred Thirty Four and Twenty cents only)
4. Country in which Inipharm Inc. has presence: USA